
The most common form of MLD usually develops in babies younger than 30 months
(Picture: PA Archive)Teddi Shaw has become the first patient in the UK to receive Libmeldy, a medication that treats the genetic flaw at the root of metachromatic leukodystrophy (MLD).
The list price of gene therapy, which replaces a damaged gene within the body's cells, is £2.8 million.